Microneedle Patch Technology
Our Mission
Our primary mission at ArrayPatch is to provide healthcare professionals with a superior treatment option, ultimately improving patient outcomes. This mission is centred around our innovative DerMap patent technology, a unique dissolvable microneedle technology.
Microneedle Patch Technology
The Science Behind DerMap
DerMap is a pain-free microneedle patch the size of a small coin that, upon application, penetrates the outer layer of the skin and begins to dissolve and release medication. A key breakthrough of the technology is that each microneedle is made entirely from the drug treatment, avoiding the need for polymers required in older technologies, thereby allowing greater drug loading for greater efficacy
Microneedle Patch Technology
The Potential Pipeline Market
GLP-DerMap™ is our lead programme, focused on delivering GLP-1 medicines for obesity and type 2 diabetes through a convenient, minimally invasive dissolving microneedle patch. Beyond GLP-DerMap™, our pipeline includes Skin Cancer DerMap™, being developed for targeted delivery of oncology medicines, and ITZ-DerMap™ for onychomycosis (nail fungal infection). The DerMap™ platform has the potential to support a broad range of peptides, small molecules and biologics, creating opportunities for additional products and strategic partnerships with pharmaceutical companies.
ArrayPatch
Meet the team
ARRAYPATCH
Our Recent News
One of just 5 European innovation case studies featured in this video!
We’re proud to be recognised alongside other European breakthroughs demonstrating how EU-funded research can move beyond the laboratory and create real-world impact. This recognition is a great reflection of the journey we are on, turning scientific innovation into technologies that can ultimately benefit patients.
Collaboration with Rinn Pharma & Biopharma and University College Cork
Advancing a novel intradermal therapy for skin cancer using our proprietary DerMap™ microneedle platform.
Together, we're working to develop more targeted, patient-friendly treatments that have the potential to improve outcomes.
Close of €3M Seed Round to Advance ITZ-DerMap™
This funding will accelerate the clinical development of ITZ-DerMap™, the first product from our proprietary polymer-free microneedle DerMap™ platform, enabling pain-free, targeted drug delivery.
The InterTradeIreland Seedcorn Winner
ArrayPatch has been announced as the overall winner of the InterTradeIreland all-island Seedcorn Investor Readiness Competition! Taking home the top prize, along with €130,000 to support their next stage.
Enterprise Ireland’s Startup Day (Big Ideas 2024) Finalist
ArrayPatch has been selected as one of ten promising investor ready startup companies and invited to pitch at Big Ideas 2024.
Business Plus Feature
Dr Waleed Faisal discusses the company’s groundbreaking microneedle-based drug delivery system, DerMap.
Winner of Ideate Ireland 2023
ArrayPatch has been named the winner of 2023 IDEATE Ireland competition and claimed the €15,000 prize.
Innovation of the Year
ArrayPatch microneedle project wins "Innovation of the Year" at the 2022 Ireland Pharma Industry Awards.
Winner of the First Start-up Retreat
ArrayPatch team won a fellowship at the "1st Start-up Retreat", in Porto, Portugal.
Ireland’s Top 100 Hospital and Healthcare Achievers
Dr Faisal (CEO and founder) was chosen among Ireland’s top hospital and healthcare achievers, HPN Professional Top 100.
Commercial Activity of the Year
ArrayPatch is the winner of the 2022 Commercial Activity of the Year.
© Copyright 2026 ArrayPatch | All Rights Reserved
3003, Courtstown, Euro Business Park, Co. Cork, Ireland